Related Experiment Videos
Aggregation of human granulocytes by Staphylococcus aureus lipase
J Rollof1, E Vinge, P Nilsson-Ehle
1Department of Infectious Diseases, University Hospital of Lund, Sweden.
Journal of Medical Microbiology
|January 1, 1992
Summary
Extracellular lipase from Staphylococcus aureus triggers human granulocyte aggregation and lactoferrin release in vitro. This effect was concentration-dependent and inhibited by autologous plasma.
Area of Science:
- Microbiology
- Immunology
- Enzymology
Background:
- Staphylococcus aureus is a common pathogen.
- Extracellular enzymes play a role in bacterial pathogenesis.
- Granulocytes are key immune cells involved in host defense.
Purpose of the Study:
- To investigate the effects of Staphylococcus aureus extracellular lipase on human granulocytes.
- To determine the mechanism of lipase-induced granulocyte activation.
Main Methods:
- In vitro study using a turbidimetric technique.
- Purified extracellular lipase from Staphylococcus aureus was used.
- Human granulocytes were exposed to varying concentrations of lipase.
Main Results:
- Lipase induced monophasic aggregation of granulocytes within a specific concentration range (0.6-4.4 µg/ml).
- Lactoferrin release was observed concurrently with granulocyte aggregation.
- The solvent (Triton X100) alone did not affect granulocytes.
- Lipase-induced aggregation was inhibited in the presence of autologous plasma.
Conclusions:
- Extracellular lipase from Staphylococcus aureus directly affects human granulocyte function.
- Lipase-mediated granulocyte aggregation and lactoferrin release suggest a role in immune modulation or evasion.
- The inhibitory effect of plasma indicates a potential protective mechanism against lipase-induced activation.